Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.

@article{Fuh2008CosteffectivenessAO,
  title={Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.},
  author={Jong-Ling Fuh and Shuu-Jiun Wang},
  journal={International journal of geriatric psychiatry},
  year={2008},
  volume={23 1},
  pages={73-8}
}
BACKGROUND Donepezil is a drug used for treatment in patients with Alzheimer's disease (AD). Information regarding the cost-effectiveness of this medication was previously rare in Asia. We used techniques of decision analysis and economic evaluation in conjunction with available local epidemiological and clinical data on costs of mild to moderate AD to assess the cost-effectiveness of donepezil in Taiwan. METHODS A four-state Markov model was built to simulate the disease progression of AD… CONTINUE READING